Agile Therapeutics Inc (AGRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -34,233 | -18,709 | -7,883 | -18,606 | -12,585 |
| Depreciation Amortization | 147 | 90 | 44 | 163 | 121 |
| Other Working Capital | 1,112 | 2,063 | -767 | 992 | -1,302 |
| Other Operating Activity | 3,005 | 1,907 | 722 | 1,762 | 1,347 |
| Operating Cash Flow | $-29,969 | $-14,649 | $-7,884 | $-15,689 | $-12,419 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -47,921 | -47,822 | N/A | N/A | N/A |
| PPE Investments | -296 | -222 | -164 | -98 | -30 |
| Investing Cash Flow | $-48,217 | $-48,044 | $-164 | $-98 | $-30 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 20,000 | 20,000 | 20,000 | N/A | N/A |
| Common Stock Issued | 48,929 | 48,719 | 48,553 | 42,415 | 22,968 |
| Other Financing Activity | -1,059 | -1,059 | -1,059 | 0 | 0 |
| Financing Cash Flow | $67,870 | $67,660 | $67,494 | $42,415 | $22,968 |
| Beginning Cash Position | 34,479 | 34,479 | 34,479 | 7,851 | 7,851 |
| End Cash Position | 24,163 | 39,446 | 93,925 | 34,479 | 18,370 |
| Net Cash Flow | $-10,316 | $4,967 | $59,446 | $26,628 | $10,519 |
| Free Cash Flow | |||||
| Operating Cash Flow | -29,969 | -14,649 | -7,884 | -15,689 | -12,419 |
| Capital Expenditure | -296 | -222 | -164 | -98 | -30 |
| Free Cash Flow | -30,265 | -14,871 | -8,048 | -15,787 | -12,449 |